Dave S. B. Hoon MSc, PhD

Dave as the founding Director of the Department of Molecular Oncology, Dr. Hoon continues to pioneer investigations of RNA/genomic/epigenomic biomarkers for diagnostic, prognostic and predictive assessment of residual tumor cells. He also spearheads investigations of circulating DNA/miRNA biomarkers for staging cancer in patients enrolled in phase II/III clinical trials.

He has coauthored more than 250 peer-reviewed articles and reviews, primarily related to translational molecular oncology of human solid tumors. Dr. Hoon has served on several review study sections as a permanent member for the National Cancer Institute and was a founding member of NCI’s Cancer Biomarker Study Section. Under Dr. Hoon’s direction the department consists of 22 MD/PhD and research technicians focused on translation molecular oncology. Dr. Hoon has trained more than 60 postdoctoral oncology fellows, who now hold faculty appointments in numerous academic institutions.